ABSTRACT
Pharmaceutical systems are framed in a healthy spirit, with the strategic objective at both, national and international level. With the aim of building long-term sustainable economic and social development, the very function of the pharmaceutical systems has emerged to be of a crucial strategic value for nations, in the sense of capacity to rapidly produce needed medication to treat and prevent disease. This study analyzes how the pharmaceutical industry, has been rearranged to give a priority to prevention and treatment of health care, then to other lines of activity. Analyses further examines how the financing of this industry involves more than financial funds and how artificial intelligence can help humanity to fight Covid-19 and future pandemics. This research was conducted through successive interviews with representatives of public institutions, in charge of developing financial and budgetary policy, representatives of the chemical industry, pharmaceutical, and medical industries, as well as representatives of higher education institutions specializing in medicine and pharmaceuticals. This research concludes that development of the pharmaceutical sector is still largely affected by various economic policy objectives, and subject to sufficient, stable, and dedicated funding. One of the conclusions derived from this study is the necessity to help public health agencies perform key public health functions such as assessments, and policy, to ensure that communities have access to the minimum package of public health services on global bases. © 2021 ACM.